Get the Stockscreener App
5.61
1.93%
-0.08
Rezolute Inc stock is traded at $5.61, with a volume of 113.91K.
It is down -1.93% in the last 24 hours and up +12.05% over the past month.
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.
See More
Previous Close:
$5.69
Open:
$5.71
24h Volume:
113.91K
Relative Volume:
0.11
Market Cap:
$485.44M
Revenue:
-
Net Income/Loss:
$-69.31M
P/E Ratio:
-4.4173
EPS:
-1.27
Net Cash Flow:
$-62.80M
1W Performance:
-6.22%
1M Performance:
+12.05%
6M Performance:
+13.65%
1Y Performance:
+30.99%
1-Day Range:
$5.56
$5.755
1-Week Range:
$5.55
$6.09
52-Week Range:
$2.215
$6.645
Rezolute Inc Stock (RZLT) Company Profile
Name
Rezolute Inc
Sector
Industry
Phone
650-206-4507
Address
275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY
Compare RZLT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RZLT
Rezolute Inc
|
5.58 | 509.80M | 0 | -69.31M | -62.80M | -1.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.43 | 96.11B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.36 | 60.40B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
430.06 | 54.91B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
670.26 | 41.30B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
295.09 | 33.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Rezolute Inc Stock (RZLT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-05-24 | Initiated | Wedbush | Outperform |
| Aug-27-24 | Initiated | Guggenheim | Buy |
| Jul-17-24 | Initiated | BTIG Research | Buy |
| Jun-04-24 | Initiated | Craig Hallum | Buy |
| Apr-09-24 | Initiated | Maxim Group | Buy |
| Aug-02-22 | Resumed | Canaccord Genuity | Buy |
| Jun-15-22 | Initiated | Cantor Fitzgerald | Overweight |
| Sep-08-21 | Initiated | ROTH Capital | Buy |
| May-27-21 | Initiated | Oppenheimer | Outperform |
| May-25-21 | Initiated | H.C. Wainwright | Buy |
View All
Rezolute Inc Stock (RZLT) Latest News
Leading vs lagging indicators on Rezolute Inc. performanceLong-Term Investment Strategy Summary Guide - Newser
How to monitor Rezolute Inc. with trend dashboardsSummary of Consistent Growth Stock Picks - Newser
Signal strength of Rezolute Inc. stock in tech scannersLong-Term Growth Trend Summary With Confidence - Newser
How to use a screener to detect Rezolute Inc. breakoutsSummary of Reliable Long-Term Trade Models - Newser
Is Rezolute Inc. still worth holding after the dipDaily Swing Candidate Analysis with Chart Patterns - Newser
Analyzing Rezolute Inc. with multi timeframe chartsBuy Opportunity Forecast for Fast Traders - Newser
Published on: 2025-08-04 00:12:24 - Newser
How strong is Rezolute Inc. company’s balance sheetHigh-yield growth strategies - Jammu Links News
What is the dividend policy of Rezolute Inc. stockMaximize your portfolio’s growth potential - Jammu Links News
Is Rezolute Inc. stock overvalued or undervaluedBreakthrough profit margins - Jammu Links News
Why is Rezolute Inc. stock attracting strong analyst attentionInvest confidently with professional guidance - Jammu Links News
What drives Rezolute Inc. stock priceRapid return acceleration - Jammu Links News
What are the latest earnings results for Rezolute Inc.Capitalize on market trends early - Jammu Links News
How does Rezolute Inc. compare to its industry peersRemarkable growth - Jammu Links News
Is it the right time to buy Rezolute Inc. stockUnlock exclusive stock market forecasts - Jammu Links News
What are analysts’ price targets for Rezolute Inc. in the next 12 monthsBuild wealth steadily with smart stock selection - Jammu Links News
What is the risk reward ratio of investing in Rezolute Inc. stockCapitalize on high-growth stocks early - Jammu Links News
Using economic indicators to assess Rezolute Inc. potentialSafe Momentum Strategy With Trend Analysis - Newser
Why Rezolute Inc. stock attracts strong analyst attentionFree Trade Setups With Clear Risk Limits - Newser
Published on: 2025-08-02 01:35:25 - Newser
What MACD and RSI say about Rezolute Inc.Free AI Powered High Return Stock Calls - Newser
What the charts say about Rezolute Inc. todayTechnical Trade Plan with Entry Checklist - Newser
Will Rezolute Inc. benefit from macro trendsStock Forecast Tools for Retail Traders - Newser
What makes Rezolute Inc. stock price move sharplyFree AI Trading Suggestions With Accuracy Focus - Newser
Published on: 2025-07-29 20:26:29 - metal.it
How Efficient Is Rezolute Inc. at Controlling Operating CostsFree AI-Powered Trade Planning with Indicators - Newser
RZLT Stock Price and Chart — NASDAQ:RZLT - TradingView
Technical Models Detect Momentum Build in Rezolute Inc.Pattern Alert With ROI Driven Strategy Shared - metal.it
Would I Buy Rezolute Inc (NASDAQ: RZLT) Stock At Any Time In The Future? - Stocksregister
What are Rezolute Inc. company’s key revenue driversHigh-margin investment plays - Jammu Links News
What are the technical indicators suggesting about Rezolute Inc.Build wealth faster with consistent investment plans - Jammu Links News
How does Rezolute Inc. generate profit in a changing economyAchieve consistent profits with expert advice - Jammu Links News
Intrinsic Value of Rezolute Inc. Stock: Is It Undervalued or OvervaluedLow Risk Picks for Daily Trading Released - metal.it
What is Rezolute Inc. company’s growth strategyUnlock daily stock market insights for success - jammulinksnews.com
How many analysts rate Rezolute Inc. as a “Buy”Free Risk Assessment Services - jammulinksnews.com
Rezolute Inc Stock (RZLT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Rezolute Inc Stock (RZLT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Evans Daron | CFO |
Jun 24 '25 |
Buy |
4.05 |
5,000 |
20,250 |
268,900 |
| Kim Young-Jin | Director |
Jun 13 '25 |
Buy |
3.25 |
1,230,769 |
3,999,999 |
8,423,386 |
| KREHER NERISSA | Director |
Jun 13 '25 |
Buy |
3.25 |
3,076 |
9,997 |
37,576 |
| Hogenhuis Wladimir | Director |
Mar 31 '25 |
Buy |
2.92 |
6,758 |
19,733 |
84,025 |
| Elam Nevan C | CEO |
Mar 27 '25 |
Buy |
2.85 |
12,302 |
34,999 |
224,119 |
| Evans Daron | CFO |
Mar 26 '25 |
Buy |
2.89 |
10,000 |
28,900 |
237,900 |
| Evans Daron | CFO |
Mar 26 '25 |
Buy |
2.88 |
10,000 |
28,800 |
23,000 |
| Hogenhuis Wladimir | Director |
Feb 18 '25 |
Buy |
4.70 |
10,000 |
47,000 |
77,267 |
| Evans Daron | CFO |
Dec 18 '24 |
Buy |
4.29 |
10,000 |
42,900 |
150,900 |
| Evans Daron | CFO |
Dec 12 '24 |
Buy |
4.60 |
9,000 |
41,400 |
140,900 |
0.36%
1.76%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):